BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7651386)

  • 1. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.
    Shin TH; Paterson AJ; Kudlow JE
    Mol Cell Biol; 1995 Sep; 15(9):4694-701. PubMed ID: 7651386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.
    Farmer G; Friedlander P; Colgan J; Manley JL; Prives C
    Nucleic Acids Res; 1996 Nov; 24(21):4281-8. PubMed ID: 8932384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
    Li B; Lee MY
    J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of the human transforming growth factor-alpha initiator.
    Shin TH; Kudlow JE
    Mol Endocrinol; 1994 Jun; 8(6):704-12. PubMed ID: 7935486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor AP2 is required for expression of the rat transforming growth factor-alpha gene.
    Berkowitz EA; Hecht CP; Azizkhan JC; Chen X; Lee DC
    Oncogene; 1997 May; 14(18):2229-38. PubMed ID: 9174059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.
    Liu X; Miller CW; Koeffler PH; Berk AJ
    Mol Cell Biol; 1993 Jun; 13(6):3291-300. PubMed ID: 8497252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of human excitatory amino acid transporter 1 (EAAT1): cloning of the EAAT1 promoter and characterization of its basal and inducible activity in human astrocytes.
    Kim SY; Choi SY; Chao W; Volsky DJ
    J Neurochem; 2003 Dec; 87(6):1485-98. PubMed ID: 14713304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of the human transforming growth factor-alpha gene.
    Raja RH; Paterson AJ; Shin TH; Kudlow JE
    Mol Endocrinol; 1991 Apr; 5(4):514-20. PubMed ID: 1922084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells.
    Han X; Patters AB; Chesney RW
    J Biol Chem; 2002 Oct; 277(42):39266-73. PubMed ID: 12163498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation by simian virus 40 large T antigen: requirements for simple promoter structures containing either TATA or initiator elements with variable upstream factor binding sites.
    Gilinger G; Alwine JC
    J Virol; 1993 Nov; 67(11):6682-8. PubMed ID: 8411370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of delayed-early gene transcription by dual TATA boxes.
    Guarino LA; Smith M
    J Virol; 1992 Jun; 66(6):3733-9. PubMed ID: 1583729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of transforming growth factor alpha expression in a growth factor-independent cell line.
    Howell GM; Humphrey LE; Ziober BL; Awwad R; Periyasamy B; Koterba A; Li W; Willson JK; Coleman K; Carboni J; Lynch M; Brattain MG
    Mol Cell Biol; 1998 Jan; 18(1):303-13. PubMed ID: 9418877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
    Liang H; Lunec J
    Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function.
    Wing BA; Johnson RA; Huang ES
    J Virol; 1998 Mar; 72(3):1814-25. PubMed ID: 9499032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping TATA-dependent and TATA-independent early promoter activities in the baculovirus gp64 envelope fusion protein gene.
    Kogan PH; Chen X; Blissard GW
    J Virol; 1995 Mar; 69(3):1452-61. PubMed ID: 7853477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal expression of the human alcohol dehydrogenase gene family during liver development correlates with differential promoter activation by hepatocyte nuclear factor 1, CCAAT/enhancer-binding protein alpha, liver activator protein, and D-element-binding protein.
    van Ooij C; Snyder RC; Paeper BW; Duester G
    Mol Cell Biol; 1992 Jul; 12(7):3023-31. PubMed ID: 1620113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters.
    Wiley SR; Kraus RJ; Mertz JE
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5814-8. PubMed ID: 1321424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.